Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat. [electronic resource]
Producer: 20140507Description: 148 p. digitalISSN:- 1475-2840
- Animals
- Cardiotonic Agents -- administration & dosage
- Disease Models, Animal
- Exenatide
- Glucagon-Like Peptide 1 -- administration & dosage
- Glucagon-Like Peptide-1 Receptor
- Immunoconjugates -- administration & dosage
- Injections, Subcutaneous
- Male
- Myocardial Contraction -- drug effects
- Myocardial Infarction -- metabolism
- Myocardial Reperfusion Injury -- metabolism
- Myocardium -- metabolism
- Peptide Fragments -- administration & dosage
- Peptides -- pharmacology
- Rats
- Rats, Sprague-Dawley
- Receptors, Glucagon -- agonists
- Serum Albumin -- immunology
- Single-Domain Antibodies -- administration & dosage
- Venoms -- pharmacology
- Ventricular Function, Left -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.